Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Clinical trial NCT04198922 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04198922
Sponsor: Fred Hutchinson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Moderate-Severe Chronic Graft Versus Host Disease Hematopoietic and Lymphoid Cell Neoplasm

Start date: 2020-12-11
Primary completion: 2025-09-29
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.